Therefore, multiple drugs used to treat diabetes are the subject of preclinical and clinical studies in AD such as insulin, metformin and more recently, analogues of glucagon-like-peptide 1 (GLP-1) [185]. This evidence concerns the gene INS and Alzheimer disease.